4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Jacobio Pharmaceuticals Group Co., Ltd. (1167) operates in the Biotechnology industry and is headquartered in Beijing, China with about 67 employees. Its market capitalization is roughly CNY 4 billion. In the fiscal year ended 2025-12-31, 1167 reported CNY 54M in revenue and (CNY 146M) in net income.
Jacobio Pharmaceuticals Group Co., Ltd., an investment holding company, engages in the in-house discovery and development of oncology therapies in the People's Republic of China.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 54M | CNY 156M | CNY 64M | CNY 96M | — |
| Gross Profit | CNY 53M | CNY 156M | CNY 3M | CNY 13M | — |
| Operating Income (EBIT) | (CNY 166M) | (CNY 203M) | (CNY 408M) | (CNY 474M) | — |
| Net Income | (CNY 146M) | (CNY 156M) | (CNY 359M) | (CNY 372M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 1.3B | CNY 1.4B | CNY 1.5B | CNY 1.6B | — |
| Total Liabilities | CNY 534M | CNY 436M | CNY 387M | CNY 292M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1167 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms